Smith Weber Lara purchased $14K of GUTS
Smith Weber Lara (Chief Financial Officer) purchased 20,000 shares of FRACTYL HEALTH, INC. (GUTS) at $0.69 on 2026-06-08.
How this was made
The 30-second read
Why it matters
The newest information is the CFO’s open-market purchase details (shares, price, and timing), which may slightly influence sentiment but does not change fundamentals on its own.
Market read
A small CFO open-market buy is disclosed; traders may note it as mild positive sentiment but should not treat it as a fundamental catalyst.
What to watch
The transaction is not under a 10b5-1 plan, but the filing alone doesn’t reveal intent, timing constraints, or whether other insiders/owners are selling.
Background
The article is an SEC EDGAR Form 4 insider transaction disclosure for FRACTYL HEALTH, INC. (GUTS).
Ticker impact
CFO Smith Weber Lara filed an SEC Form 4 open-market purchase of 20,000 GUTS shares at $0.6854 on 2026-06-08.
Likely minimal near-term price impact; any effect would be sentiment-driven and short-lived.
The filing is primary-source and directly about GUTS, but the disclosed dollar value (~$13.7k) and lack of 10b5-1 context reduce materiality for trading decisions.
Market effects
No sector read-across; this is a single-company insider transaction.
None indicated.
None indicated.
Counterpoint
Insider buys can be routine liquidity/compensation-related and may not reflect fundamental upside, especially at small dollar sizes.
Key entities
- issuerFRACTYL HEALTH, INC.
Company whose insider transaction was disclosed on SEC Form 4.
- insiderSmith Weber Lara
Chief Financial Officer who purchased 20,000 shares.
